Skip to content

Clinical trials

Completed Phase 4 Alzheimer Disease trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Phase: Phase 4 Status: Completed Clear all

86 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20023
20037
20044
20056
20066
20079
20085
20094
20105
20113
20124
20133
20146
20153
20163
20182
20192
20201
20222
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed86

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis7
Novartis Pharmaceuticals7
Avid Radiopharmaceuticals4
New York State Psychiatric Institute4
Eisai Inc.3
Eisai Korea Inc.3
NYU Langone Health3
VA Office of Research and Development3
Emory University2
Forest Laboratories2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease86
Dementia21
Cognitive Dysfunction9
Psychomotor Agitation7
Psychotic Disorders4
Cognition Disorders3
Lethargy3
Plaque, Amyloid3
Anosmia2
Dementia, Vascular2

Trials

Showing 1 to 25 of 86. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.